Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia Arne W. MouldNoura Al-JuffaliElizabeth M. Tunbridge Leading Article 20 December 2021 Pages: 1 - 16
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression Susan LingFelicia CebanRoger S. McIntyre Review Article 17 November 2021 Pages: 17 - 30
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain Frank PetzkeThomas TölleWinfried Häuser Review Article Open access 21 November 2021 Pages: 31 - 44
Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment Dejan JakimovskiSamreen AwanBianca Weinstock-Guttman Review Article 23 December 2021 Pages: 45 - 59
Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials Gerard J. MeskillCraig W. DavisJeffrey M. Dayno Original Research Article Open access 21 December 2021 Pages: 61 - 69
Pharmacokinetics, Safety, and Tolerability of SHP465 Mixed Amphetamine Salts After Administration of Multiple Daily Doses in Children Aged 4–5 Years with Attention-Deficit/Hyperactivity Disorder Katarina IlicAlan R. KuglerNora McNamara Original Research Article Open access 26 November 2021 Pages: 71 - 81
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study Serena PalmeriMarta PonzanoAlice Laroni Original Research Article 11 December 2021 Pages: 83 - 96
Correction to: Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively Samuel R. ChamberlainDavid S. Baldwin Correction 25 November 2021 Pages: 97 - 97
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy Sheridan M. Hoy Correction Open access 27 December 2021 Pages: 99 - 99
Comment on: “Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively” Sven Ulrich Letter to the Editor 07 December 2021 Pages: 101 - 102
Authors’ Reply to Ulrich: Comment on ‘Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use Them Safely and Effectively’ David S. BaldwinSamuel R. Chamberlain Letter to the Editor 07 December 2021 Pages: 103 - 103